|
|
Mechanisms of Leukemogenesis in Down Syndrome |
| 5R01CA101774-18 |
CRISPINO, JOHN D |
NCI |
2020 |
|
|
Carbidopa as an inhibitor of the TrpT/ID01 functional complex: A novel immunotherapy agent |
| 5R03CA223271-02 |
BHUTIA, YANGZOM DOMA |
NCI |
2020 |
|
|
Evaluation of myocardial targets to prevent anthracycline cardiotoxicity in children with Down Syndrome and Leukemia |
| 5R21CA245067-02 |
BLANCO, JAVIER G |
NCI |
2020 |
|
|
Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia |
| 1 R01 EY030434-01A1 |
NASR, SHAHIN |
NEI |
2020 |
|
|
Multisensory Pathways and Plasticity Following Partial and Full Vision Loss |
| 1 R01 EY031761-01 |
DELUCIA, PATRICIA ROSE |
NEI |
2020 |
|
|
Exploring the role of gonadotropins in Down syndrome |
| 1 R21 EY032320-01 |
KARAMICHOS, DIMITRIOS |
NEI |
2020 |
|
|
Genetics & Genomics of Fuchs Endothelial Corneal Dystrophy |
| 5R01EY022161-09 |
MOOTHA, VENKATESWARA VINOD |
NEI |
2020 |
|
|
Visual Field Expansion Through Innovative Multi-periscopic Prism Design |
| 5R01EY023385-07 |
PELI, ELI |
NEI |
2020 |
|
|
Intravenous MitoTargeted AAV9 Gene Therapy for Treatment of Visual Loss and Encephalopathy in Leigh Syndrome and NARP |
| 5R01EY027414-04 |
YU, HONG |
NEI |
2020 |
|
|
Application of RNA-targeting Cas9 to Fuchs dystrophy |
| 5R01EY029166-03 |
YEO, EUGENE WEI-MING |
NEI |
2020 |
